The Affordable Care Act sets up a comparative effectiveness research (CER) institute, but specifically bars the results of this research from being used in Medicare coverage decisions. Yet there's a ...
The objectives of this article are (1) to examine the similarities and differences between comparative effectiveness research (CER) and evidence-based medicine (EBM); (2) to describe the implications ...
Efficacy and safety of talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Updated results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results